DMAC CIK: 1401040

DiaMedica Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
45.4
FY22:
33.8
FY23:
53.7
FY24:
44.6
FY25:
60.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.11
FY22:
0.56
FY23:
0.49
FY24:
1.74
FY25:
0.74
Total assets
Change from FY21 to FY25
millions USD
FY21:
45.6
FY22:
34.4
FY23:
54.2
FY24:
46.3
FY25:
61.4

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
1.52
FY22:
2.17
FY23:
2.79
FY24:
5.39
FY25:
5.13
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.00
FY22:
0.40
FY23:
0.32
FY24:
0.24
FY25:
0.13
(positive)
Change from FY21 to FY25
millions USD
FY21:
44.0
FY22:
31.8
FY23:
51.1
FY24:
40.7
FY25:
56.1
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
45.6
FY22:
34.4
FY23:
54.2
FY24:
46.3
FY25:
61.4

All amounts in millions USD Data sources:SEC EDGARTwelve Data